Brief: Rigel Pharmaceuticals Provides Business Update

Rigel Pharmaceuticals

09/01/2023 13:35

Jan 9 (Reuters) - Rigel Pharmaceuticals Inc  RIGL.O :
    * RIGEL PHARMACEUTICALS INC SEES Q4 REVENUE ABOUT $51.3
MILLION
    * RIGEL PHARMACEUTICALS PROVIDES BUSINESS UPDATE
    * RIGEL PHARMACEUTICALS - PRELIMINARY Q4 2022 NET PRODUCT
SALES OF
ABOUT $21.9 MILLION AND REZLIDHIA PRELIMINARY NET PRODUCT SALES
OF APPROXIMATELY $0.9 MILLION
    * RIGEL PHARMACEUTICALS INC - EXPECTS TO REPORT CASH, CASH
EQUIVALENTS, AND SHORT-TERM INVESTMENTS AS OF DECEMBER 31, 2022,
OF APPROXIMATELY $58.2 MILLION
    * RIGEL PHARMACEUTICALS INC - CONTRACT REVENUES FOR Q4 OF
2022 ARE
EXPECTED TO BE APPROXIMATELY $28.5 MILLION

Source text for Eikon:  ID:nPn97T0fHa 
Further company coverage:  RIGL.O 
 ((Reuters.Briefs@thomsonreuters.com;;))